GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » Institutional Ownership

XYLO (Xylo Technologies) Institutional Ownership : 4.39% (As of Apr. 19, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Xylo Technologies's institutional ownership is 4.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Xylo Technologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Xylo Technologies's Float Percentage Of Total Shares Outstanding is 97.45%.


Xylo Technologies Institutional Ownership Historical Data

The historical data trend for Xylo Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies Institutional Ownership Chart

Xylo Technologies Historical Data

The historical data trend for Xylo Technologies can be seen below:

2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31
Institutional Ownership 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03

Xylo Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Xylo Technologies Business Description

Traded in Other Exchanges
N/A
Address
10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.